Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
Gold R, Radue EW, Giovannoni G, Selmaj K, Havrdova EK, Montalban X, Stefoski D, Sprenger T, Robinson RR, Fam S, Smith J, Chalkias S, Giannattasio G, Lima G, Castro-Borrero W. Gold R, et al. Among authors: smith j. J Neurol. 2020 Oct;267(10):2851-2864. doi: 10.1007/s00415-020-09835-y. Epub 2020 May 25. J Neurol. 2020. PMID: 32451615 Free PMC article. Clinical Trial.
A Bogey of the Mind.
Smith JH. Smith JH. Neurology. 2023 Nov 7;101(19):853-854. doi: 10.1212/WNL.0000000000207759. Epub 2023 Aug 14. Neurology. 2023. PMID: 37580169 Free PMC article. No abstract available.
The 5-year Tysabri global observational program in safety (TYGRIS) study confirms the long-term safety profile of natalizumab treatment in multiple sclerosis.
Foley J, Carrillo-Infante C, Smith J, Evans K, Ho PR, Lee L, Kasliwal R, Stangel M, Vermersch P, Hutchinson M, Marinelli F, Smirnakis K; TYGRIS investigators. Foley J, et al. Among authors: smith j. Mult Scler Relat Disord. 2020 Apr;39:101863. doi: 10.1016/j.msard.2019.101863. Epub 2019 Nov 21. Mult Scler Relat Disord. 2020. PMID: 31901758
Oral cannabidiol did not impair learning and memory in healthy adults.
Gebregzi HH, Zeiger JS, Smith JP, Stuyt L, Cullen L, Carsella J, Rogers DC, Lafebre J, Knalfec J, Vargas A, Diawara MM. Gebregzi HH, et al. Among authors: smith jp. J Cannabis Res. 2025 Jan 23;7(1):5. doi: 10.1186/s42238-025-00262-2. J Cannabis Res. 2025. PMID: 39849639
Survival Among Patients Treated with Total Mesorectal Excision or Selective Watch-and-Wait After Total Neoadjuvant Therapy: A Pooled Analysis of the CAO/ARO/AIO-12 and OPRA Randomized Phase II Trials.
Williams H, Fokas E, Diefenhardt M, Lee C, Verheij FS, Omer DM, Lin ST, Dunne RF, Marcet J, Cataldo P, Polite B, Piso P, Polat B, Dapper H, Ghadimi M, Hofheinz RD, Qin LX, Saltz LB, Wu AJ, Gollub MJ, Smith JJ, Weiser MR, Rödel C, Garcia-Aguilar J; German Rectal Cancer Study Group; OPRA Consortium. Williams H, et al. Among authors: smith jj. Ann Oncol. 2025 Jan 21:S0923-7534(25)00010-9. doi: 10.1016/j.annonc.2025.01.006. Online ahead of print. Ann Oncol. 2025. PMID: 39848335
Phenotypic and genotypic characterization of Mycobacterium tuberculosis pyrazinamide resistance-India, 2018-2020.
Tamilzhalagan S, Justin ES, Selvaraj A, Venkateswaran K, Sivakumar AK, Chittibabu S, McLaughlin HP, Moonan PK, Smith JP, Suba S, Sathya Narayanan MK, Ho CS, Kumar N, Tripathy SP, Shanmugam SK, Hall-Eidson PJ, Ranganathan UD. Tamilzhalagan S, et al. Among authors: smith jp. Front Microbiol. 2025 Jan 8;15:1515627. doi: 10.3389/fmicb.2024.1515627. eCollection 2024. Front Microbiol. 2025. PMID: 39845030 Free PMC article.
33,866 results
You have reached the last available page of results. Please see the User Guide for more information.